Presentation ACC 2025 Oral Semaglutide Reduces Cardiovascular Events in People with Type 2 Diabetes with Atherosclerotic Cardiovascular and/or Chronic Kidney Disease: Primary Results From the SOUL Randomized Trial Presenter: Darren K. McGuire March 29, 2025
Presentation ACC 2024 Comparison of an “Inclisiran First” Strategy With Usual Care in Patients With Atherosclerotic Cardiovascular Disease: Results From the VICTORION-INITIATE Randomized Trial Presenter: Michael J. Koren April 06, 2024
Presentation ACC 2023 A Randomized Trial Assessing The Impact Of Eliminating Copayment For High Value Preventive Medications For Low-income Seniors With Cardiovascular-related Chronic Diseases Presenter: Braden Manns March 06, 2023
Presentation ACC 2023 A Cluster Randomized Trial of a Personalized Clinical Decision Support Intervention to Improve Statin Prescribing in Patients With Atherosclerotic Cardiovascular Disease (PCDS Statin) Presenter: Salim Virani March 05, 2023
Presentation ACC 2023 A Cluster-Randomized Trial to Improve Care of Patients in Cardiology Clinics with Type 2 Diabetes and Atherosclerotic Cardiovascular Disease [COORDINATE-Diabetes] Presenter: Neha J. Pagidipati March 05, 2023
Presentation ESC 2022 Long-Term Evolocumab in Patients with Established Atherosclerotic Cardiovascular Disease: Primary Results of the FOURIER-OLE (Open-Label Extension) Studies Presenter: Michelle L. O’Donoghue August 29, 2022
Presentation AHA 2018 Safety and Efficacy of AKCEA-APO(a)-LRx to Lower Lipoprotein(a) Levels in Patients With Established Cardiovascular Disease: A Phase 2 Dose-Ranging Trial Presenter: Sotirios Tsimikas November 11, 2018
Presentation ACC 2018 Cardiovascular Safety of Febuxostat or Allopurinol in Patients with Gout and Cardiovascular Disease (The CARES Trial) Presenter: William B. White March 11, 2018
Presentation Chronic Ischaemic Cardiovascular Disease (CICD) ESC Pilot Registry: 6-Month Follow-Up January 19, 2018
Presentation ESC 2017 Rivaroxaban With or Without Aspirin in Stable Cardiovascular Disease Presenter: John Eikelboom August 27, 2017
Presentation Availability and Affordability of Cardiovascular Disease Medicines and Their Effect on Use in High-, Middle-, and Low-Income Countries Presenter: R. Khatib October 26, 2015